Stock VIRI VIRIOS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Virios Therapeutics, Inc.

Equities

VIRI

US92829J1043

Real-time Estimate Cboe BZX
Other stock markets
 17:37:47 13/05/2024 BST 		5-day change 1st Jan Change
0.362 USD +2.00% Intraday chart for Virios Therapeutics, Inc. -13.80% -38.54%
05-09 Transcript : Virios Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024
05-09 Virios Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
AQ
Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
AQ
Virios Therapeutics to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
AQ
Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID
AQ
Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
AQ
Virios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress and Key Upcoming Milestones
AQ
Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
AQ
Virios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress and Key Upcoming Milestones
AQ
Virios Therapeutics Announces Plans to Advance Development of IMC-2 as Treatment for Symptoms Associated with Long-COVID
AQ
Virios Therapeutics, Inc. Reaches Alignment with FDA on Requirements for Advancing Development Candidate IMC-2 as Treatment for Long-COVID
AQ
Virios Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update
AQ
Virios Therapeutics to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023
AQ
Thinking about buying stock in Aware, Virios Therapeutics, Bit Brother, Confluent, or Blue Star Foods?
PR
Virios Therapeutics to Present at the ThinkEquity Conference on Thursday, October 19, 2023
AQ
Virios Therapeutics Announces Termination of At-The-Market Sales Agreement
AQ
Virios Therapeutics CEO Greg Duncan to Present at the SHARE Series Investor Event on Monday, September 18, 2023
AQ
Virios Therapeutics CEO Greg Duncan to Present at the SHARE™️ Series Investor Event on Monday, September 18, 2023
AQ
Virios Therapeutics Announces Halt to At-The-Market Offering Sales
AQ
Virios Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
AQ
Virios Therapeutics Announces Plans to Advance Lead Candidate IMC-1 to Phase 3 Development as a New Treatment Option for Fibromyalgia
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VIRI Stock
  4. News Virios Therapeutics, Inc.
  5. Press Releases